Tag Archives: Lasix

Racing Talk

Sunday’s Racing Talk

Leave a comment

DSC_0423

Mondialiste won the Arlington Millionen – what a job by David O’Meara yet again, giving this horse every chance to score at the highest level. This trainer knows how to get the most out of his stock!

Mondialiste would certainly not be able to win a Group 1 in the UK or Ireland, but against slightly lesser opposition, he took full advantage of conditions to suit him down to the grounds at Chicago last night.

Sure, the lasix treatment helps – let’s not be fooled, it’s not only the good hay and sunny air in North America that sees this horse improve so dramatically.

On his three visits to the US, Mondialiste now won two major Grade 1’s and was a fast finishing runner-up behind Tepin in another one.

That could be surprising, but given lasix as race day medication is clearly performance enhancing, with quite often dramatically positive effects on European trained horses, it’s actually not a surprise.

But take nothing away from trainer and horse  – the rules are there for everyone and David O’Meara plays within them. So well done!

———-

2.55 Deauville: Prix Jacques Le Marois (Group 1)

What a race in prospect! Several classy milers go to post at Deauville this afternoon and that makes it hard to pick a winner.

2000 Guineas hero Galileo Gold is the 7/4 favourite and has the form in the book to have a big say once again, though the has been on the go for a while now and this might be one race too many.

He meets Godolphin’s Ribchester again, who was a strong finishing third, only a shoulder behind Galileo Gold, in the Sussex Stakes last month. Ribchester is rapidly improving and a first top level success looms large.

Last years winner Esoterique has had a quiet year so far, though a recent fourth in the Prix Rothschild promises an upward form curve.

Vadamos already scored twice in Group company this year and rates a big danger – whether he is quite up to Group 1 standard remains to be seen. However he beat Ervedeya on her seasonal debut back in May.

These two go head to head here today – Vadamos with better recent form. Ervedeya, a three times Group 1 winner, seemed to need the run on reappearance but was a surprising no-show in the Queen Anne Stakes. She has to be back to her best to feature today.

That says I keep faith with her. She’s a brilliant filly on her day and if she can improve from those last two runs she must have a proper chances of beating the boys here.

Selection: Ervedeya @ 8/1 Ladbrokes

———-

2.15 Pontefract: Sky Gypsy @ 12/1 Coral: Sire Dandy Man with 100 place strike race with two years olds as this odd track, from a limited sample size, yet seemingly significant enough to have a punt.

USA

No Lasix for Mubtaahij

Leave a comment

Knowing Mike De Kock, it doesn’t come as a surprise, but it is still a brave move – the South African handler has opted against the use of Lasix for his Kentucky Derby runner Mubtaahji. De Kock argues:

“He’s never run on it, he doesn’t bleed, and I’m not prepared to take my chances running him on a substance he’s never run on before. … He’s good enough without it. I’m not experienced enough to say whether Thoroughbreds in general will or won’t run well on Lasix … If I gave him Lasix he may run better, he may run worse, but I’m not going to experiment. Lasix is not even a consideration for him.”

Source: BloodHorse.com

Obviously as someone who condemns the use of Lasix as race day medication I applaud this decision. In fact I admire his decision! Because let’s be honest, most foreign trainers do use Lasix once they send over their horses to the US. And one could argue: Rightly so.

My point of view is that Lasix is a performance enhancing drug. Actually, did anyone ever seriously doubted that? I mean this drug seems particularly effective if horses run on it for the first time. Naturally, these are often foreign raiders on their first ever visit to the US. There are many examples of horses improving dramatically. You’ve ever heard of Main Sequence?

But my favourite example is the filly Dank. A good filly, a Group 3 winner in Europe – but once on Lasix, she looked like on a different planet! I’d say she was literally flying in the Beverly D. Stakes at Arlington. Yes, maybe only a US Turf Grade 1, against weaker opposition than she would probably meet in Europe – still, the sheer acceleration… spectacular! Unbelievable!

Another fact to my point: She beat the very good filly Duntle by more than six lengths that day – she wasn’t even close to do that when these two met before. Not to mention multiple Grade 1 winning mare Marketing Mix, beaten by almost six lengths either! Further to his: If I have it right in mind, Duntle actually didn’t run on Lasix that day at Arlington.

Now, this is only the most dramatic example which comes to my mind when I think about the use of Lasix and the possible improvement it can bring out. There are many more, if you search for it, though. That says, it can’t make poor horses fly and doesn’t work for everyone. Of course not. If you’re not good enough, you’re not enough anyway. But there’s no doubt, that Lasix can bring out some improvement in good horses. It’s a performance enhancer. Simple as that.

That brings me back to the more present moment: De Kock opting against Lasix. As much as I applaud this decision , you have to wonder if it is a wise move from a pure performance point of view. Doesn’t this lower the chances of Mubtaahij to win the Derby? Yes, it absolutely does in my mind. He’s running against a bunch of US horses doped to the maximum (exaggeratedly spoken – but true to an extend). It certainly doesn’t make this mighty task any easier.

On the other hand, you got to trust the wise man – Mike De Kock. He’s a brilliant trainer, and If he believes this horse is good enough to take on a top class US Derby generation, even without Lasix,… well you know, chances arereal that the horse is good enough indeed!